Extended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine.
Rafael Dezen GaiollaSarah HartleyAmy BeechHelen KnightDean SmithMark BishtonChristopher P FoxNicolas Martinez-CallePublished in: Hematological oncology (2020)